← Open Payments lookup

CHRISTOPHER LOVELL: Open Payments

NPI 1861808230 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$23,532 in 171 payments from 18 companies in 2025. Trend: 2023 $12,641 · 2024 $15,469 · 2025 $23,532

Speaker / faculty: $15,380Food & beverage: $4,366Travel & lodging: $3,381Consulting: $405
CompanyPaymentsAmount
Madrigal Pharmaceuticals33$9,032
ABBVIE INC.58$7,465
Gilead Sciences, Inc.32$5,912
Novo Nordisk Inc5$201
Ipsen Biopharmaceuticals, Inc8$199
Intercept Pharmaceuticals, Inc.4$180
Takeda Pharmaceuticals U.S.A., Inc.5$107
Phathom Pharmaceuticals, Inc.7$72
Janssen Biotech, Inc.3$55
GENZYME CORPORATION2$54

Products named: REZDIFFRA, MAVYRET, Epclusa, RINVOQ, Wegovy, IQIRVO, CREON, OCALIVA.

Industry payments across AL — which companies pay providers there.